H型高血压患者应用依那普利联合叶酸治疗的价值分析

Value Analysis of Enalapril combined with Folic Acid in Patients with Type H Hypertension

目的观察依那普利和叶酸片联合方案治疗H型高血压的临床疗效。方法纳入2016年10月至2018年2月的116例H型高血压患者,将其随机分入对照组和研究组,给予全部患者依那普利片,研究组加服叶酸片。统计两组治疗效果。结果研究组和对照组血压和Hcy水平均有所改善,研究组改善程度更佳(P<0.05);研究组心脑血管事件共2起,少于对照组的9起(P<0.05);研究组治疗总有效率为96.6%,高于对照组的79.3%(P<0.05)。结论依那普利和叶酸片联合方案能够有效改善H型高血压患者血压指标和Hcy水平,减少心脑血管意外事件,强化临床疗效。

Objective To observe the clinical efficacy of enalapril combined with Folic Acid Tablets in the treatment of type H hypertension. Methods 116 patients with H type hypertension from October 2016 to February 2018 were randomly divided into the control group and the study group. All the patients were given enalapril and the study group was added to the Folic Acid Tablets. The effects of the two groups were statistically analyzed. Results The blood pressure and Hcy level were improved in both the study group and the control group（P〈 0.05）, and the cardiovascular and cerebrovascular events in the study group were 2, less than 9 in the control group（P〈 0.05）, and the total effective rate of the study group was 96.6%, higher than that of the control group（P〈 0.05）. Conclusion The combined regimen of enalapril and Folic Acid Tablets can effectively improve the blood pressure index and Hcy level in patients with type H hypertension, reduce the accident of cardiovascular and cerebrovascular diseases and strengthen the clinical effect.